"Low-risk groups" deserve more attention than "high-risk groups" in imported COVID-19 cases

被引:0
|
作者
Zheng, Wanshan [1 ]
Tan, Ying [1 ]
Zhao, Zedi [1 ]
Chen, Jin [1 ]
Dong, Xiaomei [1 ]
Chen, Xiongfei [2 ]
机构
[1] Jinan Univ, Sch Med, Dept Publ Hlth & Prevent Med, Guangzhou, Guangdong, Peoples R China
[2] Guangzhou Ctr Dis Control & Prevent, Guangzhou, Guangdong, Peoples R China
关键词
COVID-19; imported case; quarantine period; time interval; risk factor; VARIANT;
D O I
10.3389/fmed.2023.1293747
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To estimate the optimal quarantine period for inbound travelers and identify key risk factors to provide scientific reference for emerging infectious diseases. Methods: A parametric survival analysis model was used to calculate the time interval between entry and first positive nucleic acid test of imported cases in Guangzhou, to identify the influencing factors. And the COVID-19 epidemic risk prediction model based on multiple risk factors among inbound travelers was constructed. Results: The approximate 95th percentile of the time interval was 14 days. Multivariate analysis found that the mean time interval for inbound travelers in entry/exit high-risk occupations was 29% shorter (OR 0.29, 95% CI 0.18-0.46, p < 0.0001) than that of low-risk occupations, those from Africa were 37% shorter (OR 0.37, 95% CI 0.17-0.78, p = 0.01) than those from Asia, those who were fully vaccinated were 1.88 times higher (OR 1.88, 95% CI 1.13-3.12, p = 0.01) than that of those who were unvaccinated, and those in other VOC periods were lower than in the Delta period. Decision tree analysis showed that a combined entry/ exit low-risk occupation group with Delta period could create a high indigenous epidemic risk by 0.24. Conclusion: Different strata of imported cases can result in varying degrees of risk of indigenous outbreaks. "low-risk groups" with entry/exit low-risk occupations, fully vaccinated, or from Asia deserve more attention than "high-risk groups."
引用
收藏
页数:8
相关论文
共 50 条
  • [31] Early combination therapy of COVID-19 in high-risk patients
    Orth, Hans Martin
    Flasshove, Charlotte
    Berger, Moritz
    Hattenhauer, Sandra Tessa
    Biederbick, Kaja D.
    Mispelbaum, Rebekka
    Klein, Uwe
    Stemler, Jannik
    Fisahn, Matthis
    Doleschall, Anna D.
    Baermann, Ben-Niklas
    Koenigshausen, Eva
    Tselikmann, Olga
    Killer, Alexander
    de Angelis, Clara
    Gliga, Smaranda
    Stegbauer, Johannes
    Spuck, Nikolai
    Silling, Gerda
    Rockstroh, Juergen K.
    Strassburg, Christian P.
    Brossart, Peter
    Panse, Jens P.
    Jensen, Bjoern-Erik Ole
    Luedde, Tom
    Boesecke, Christoph
    Heine, Annkristin
    Cornely, Oliver A.
    Monin, Malte B.
    INFECTION, 2024, 52 (03) : 877 - 889
  • [32] More Than a COVID-19 Response: Sustaining Mutual Aid Groups During and Beyond the Pandemic
    Fernandes-Jesus, Maria
    Mao, Guanlan
    Ntontis, Evangelos
    Cocking, Chris
    McTague, Michael
    Schwarz, Anna
    Semlyen, Joanna
    Drury, John
    FRONTIERS IN PSYCHOLOGY, 2021, 12
  • [33] Arterial thromboembolic complications in COVID-19 in low-risk patients despite prophylaxis
    Griffin, Daniel O.
    Jensen, Alexandra
    Khan, Mushmoom
    Chin, Jessica
    Chin, Kelly
    Parnell, Ryan
    Awwad, Christopher
    Patel, Darshan
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 190 (01) : E11 - E13
  • [34] Impact of COVID-19 predicts perceived risk more strongly than known demographic risk factors
    Seehuus, Martin
    Stanton, Amelia M.
    Handy, Ariel B.
    Haik, Amanda K.
    Gorman, Rebecca
    Clifton, Jessica
    JOURNAL OF PSYCHOSOMATIC RESEARCH, 2021, 140
  • [35] Risk assessment of imported COVID-19 in China: A modelling study in Sichuan Province
    Zhang, Lei
    Zhang, Lu
    Lai, Li
    Du, Zhanwei
    Huang, Yuling
    Su, Jianming
    Wu, Canglang
    Yang, Shujuan
    Jia, Peng
    TRANSBOUNDARY AND EMERGING DISEASES, 2022, 69 (06) : 3433 - 3448
  • [36] Impact of COVID-19 and COVID-19 vaccination on high-risk patients with antiphospholipid syndrome: a nationwide survey
    Pengo, Vittorio
    Del Ross, Teresa
    Tonello, Marta
    Andreoli, Laura
    Tincani, Angela
    Gresele, Paolo
    Silvestri, Elena
    Simioni, Paolo
    Campello, Elena
    Hoxha, Ariela
    Falanga, Anna
    Ghirarduzzi, Angelo
    Denas, Gentian
    RHEUMATOLOGY, 2022, 61 (SI2) : SI136 - SI142
  • [37] COVID-19 vaccine acceptance among high-risk populations in Uganda
    Bongomin, Felix
    Olum, Ronald
    Andia-Biraro, Irene
    Nakwagala, Frederick Nelson
    Hassan, Khalid Hudow
    Nassozi, Dianah Rhoda
    Kaddumukasa, Mark
    Byakika-Kibwika, Pauline
    Kiguli, Sarah
    Kirenga, Bruce J.
    THERAPEUTIC ADVANCES IN INFECTIOUS DISEASE, 2021, 8
  • [38] Pregnancy and COVID-19: high or low risk of vertical transmission
    Hayder M. Al-kuraishy
    Ali I. Al-Gareeb
    Nisreen Khalid Aref Albezrah
    Haitham Ahmed Bahaa
    Maisra M. El-Bouseary
    Athanasios Alexiou
    Shatha Hallal Al-Ziyadi
    Gaber El-Saber Batiha
    Clinical and Experimental Medicine, 2023, 23 : 957 - 967
  • [39] Propagation dynamics of COVID-19 in high-risk population dynamic network
    Shi Y.-Y.
    Nian F.-Z.
    Liu J.-S.
    Cao J.
    Kongzhi Lilun Yu Yingyong/Control Theory and Applications, 2020, 37 (03): : 461 - 468
  • [40] Precision recruitment for high-risk participants in a COVID-19 cohort study
    Mezlini, Aziz M.
    Caddigan, Eamon
    Shapiro, Allison
    Ramirez, Ernesto
    Kondow-McConaghy, Helena M.
    Yang, Justin
    DeMarco, Kerry
    Naraghi-Arani, Pejman
    Foschini, Luca
    CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS, 2023, 33